Phenanthroindolizidine compound and NFκB inhibitor containing same as active ingredient

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9174979
APP PUB NO 20110201638A1
SERIAL NO

13125698

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A novel compound having an excellent NFκB inhibitory effect is provided and specifically disclosed is a compound represented by the following formula (1) or a salt thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KABUSHIKI KAISHA YAKULT HONSHA1-10-30 KAIGAN MINATO-KU TOKYO 1058660 ?1058660

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hashimoto, Shusuke Minato-ku, JP 19 97
Ikeda, Takashi Minato-ku, JP 403 3689
Matsuzaki, Takeshi Minato-ku, JP 22 435
Sawada, Seigo Minato-ku, JP 27 704
Yaegashi, Takashi Minato-ku, JP 29 320
Yamazaki, Ryuta Minato-ku, JP 16 49

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 3, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00